PET-CT in the staging and treatment of non-small-cell lung cancer

被引：15
作者：
Ibeas, Patricia [1 ]
Cantos, Blanca [1 ]
Manuel Gasent, Jose [1 ]
Rodriguez, Begona [2 ]
Provencio, Mariano [1 ]
机构：
[1] Hosp Univ Puerta Hierro Majadahonda, Med Oncol Serv, ES-28222 Madrid, Spain
[2] Hosp Univ Puerta Hierro Majadahonda, Nucl Med Serv, ES-28222 Madrid, Spain
来源：
CLINICAL & TRANSLATIONAL ONCOLOGY | 2011年 / 13卷 / 06期
关键词：
PET; Lung; Cancer; Diagnose; CT/PET; POSITRON-EMISSION-TOMOGRAPHY; STANDARDIZED UPTAKE VALUE; GROSS TUMOR VOLUME; FDG-PET; COMPUTED-TOMOGRAPHY; F-18; FLUORODEOXYGLUCOSE; PROGNOSTIC VALUE; HIGH-IMPACT; MEDIASTINAL METASTASES; RADICAL RADIOTHERAPY;
D O I：
10.1007/s12094-011-0670-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Positron emission tomography with 2-(F-18)-fluoro-2-deoxy-D-glucose (FDG-PET) is a metabolic imaging technique. FDG-PET is more accurate than CT for the evaluation of mediastinal involvement in patients with non-small-cell lung cancer, offering a high negative predictive value. It can detect occult metastases in 11% of patients, although the etiology of the extrathoracic isolated uptakes needs confirmation. Theoretically, FDG-PET can influence the planning volume for radiotherapy, primarily in patients with atelectasis. Quantification of metabolic activity using FDG-PET is influenced by the size of the lesion, glucose levels and the time elapsed since the isotope injection. More clinical trials are required to standardize the methods for performing PET, assess its use as a prognostic factor and for the evaluation of treatment response.
引用
收藏
页码：368 / 377
页数：10
相关论文
共 129 条
[31]   [18F]fluorodeoxyglucose positron emission tomography and its prognostic value in lung cancer [J].
Dhital, K ;
Saunders, CAB ;
Seed, PT ;
O'Doherty, MJ ;
Dussek, J .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2000, 18 (04) :425-428
[32]   Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection [J].
Downey, RJ ;
Akhurst, T ;
Gonen, M ;
Vincent, A ;
Bains, MS ;
Larson, S ;
Rusch, V .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (16) :3255-3260
[33]   LUNG-TUMOR GROWTH CORRELATES WITH GLUCOSE-METABOLISM MEASURED BY FLUORIDE-18 FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY [J].
DUHAYLONGSOD, FG ;
LOWE, VJ ;
PATZ, EF ;
VAUGHN, AL ;
COLEMAN, E ;
WOLFE, WG .
ANNALS OF THORACIC SURGERY, 1995, 60 (05) :1348-1352
[34]   Metastases from non-small cell lung cancer: Mediastinal staging in the 1990s - Meta-analytic comparison of PET and CT [J].
Dwamena, BA ;
Sonnad, SS ;
Angobaldo, JO ;
Wahl, RL .
RADIOLOGY, 1999, 213 (02) :530-536
[35]   FDG PET of pleural effusions in patients with non-small cell lung cancer [J].
Erasmus, JJ ;
McAdams, HP ;
Rossi, SE ;
Goodman, PC ;
Coleman, RE ;
Patz, EF .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2000, 175 (01) :245-249
[36]   Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET) [J].
Erdi, YE ;
Rosenzweig, K ;
Erdi, AK ;
Macapinlac, HA ;
Hu, YC ;
Braban, LE ;
Humm, JL ;
Squire, OD ;
Chui, CS ;
Larson, SM ;
Yorke, ED .
RADIOTHERAPY AND ONCOLOGY, 2002, 62 (01) :51-60
[37]   18F-FDG PET for assessment of therapy response and preoperative re-evaluation after neoadjuvant radio-chemotherapy in stage III non-small cell lung cancer [J].
Eschmann, Susanne Martina ;
Friedel, Godehard ;
Paulsen, Frank ;
Reimold, Matthias ;
Hehr, Thomas ;
Budach, Wilfried ;
Langen, Heinz-Jakob ;
Bares, Roland .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 (04) :463-471
[38]   Preoperative Staging of Lung Cancer with Combined PET-CT. [J].
Fischer, Barbara ;
Lassen, Ulrik ;
Mortensen, Jann ;
Larsen, Soren ;
Loft, Annika ;
Bertelsen, Anne ;
Ravn, Jesper ;
Clementsen, Paul ;
Hogholm, Asbjorn ;
Larsen, Klaus ;
Rasmussen, Torben ;
Keiding, Susanne ;
Dirksen, Asger ;
Gerke, Oke ;
Skov, Birgit ;
Steffensen, Ida ;
Hansen, Hanne ;
Vilmann, Peter ;
Jacobsen, Grete ;
Backer, Vibeke ;
Maltbaek, Niels ;
Pedersen, Jesper ;
Madsen, Henrik ;
Nielsen, Henrik ;
Hojgaard, Liselotte .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (01) :32-39
[39]   Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer [J].
Flamen, P ;
Van Cutsem, E ;
Lerut, A ;
Cambier, JP ;
Haustermans, K ;
Bormans, G ;
De Leyn, P ;
Van Raemdonck, D ;
De Wever, W ;
Ectors, N ;
Maes, A ;
Mortelmans, L .
ANNALS OF ONCOLOGY, 2002, 13 (03) :361-368
[40]  
GARRIDO MR, 2004, PET TAC INDICACIONES
12345678910